Diabetes

DUBLIN, Ohio — Cardinal Health on Monday announced the availability of free, downloadable materials to help community pharmacists educate patients about effective strategies for preventing and living with diabetes as part of National Diabetes Awareness Month. 

BAGSVÆRD, Denmark — A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

Novo Nordisk said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had voted 8-to-4 in favor of approval for insulin degludec and a combination treatment containing insulin degludec and insulin aspart.

IRVINE, Calif. – Links Medical Products Animal Health Group on Thursday announced the introduction of their new Pet Gluco blood-glucose monitoring system for dogs and cats.

WOONSOCKET, R.I. — MinuteClinic is offering free diabetes screenings during November to mark Diabetes Month.

Whatever dazzling visions science fiction may offer of the widgets of the future, the long, uphill road of technology inevitably leads to the smaller and the simpler. The horse and carriage gave way to the automobile; vacuum tubes gave way to transistors; and computers that took up entire rooms and required intricate climate-control technologies now fit in one’s pocket. 


Technologies used in health care have undergone a similar transition, and much of that has happened in the last few years thanks to the spread of mobile technology. 


CAMP HILL, Pa. — Rite Aid is renewing its diabetes extension for Wellness+ and offering free screenings at all of its Wellness stores to mark American Diabetes Month, the retail pharmacy chain said Monday.

Here’s a chilling statistic to ponder: Every 24 hours, more than 4,000 adults in the United States are diagnosed with diabetes, and some 200 die from its effects. That’s according to the Centers for Disease Control and Prevention, which also reports that diabetes afflicts roughly 26 million Americans and could eventually develop in another 79 million U.S. residents considered to have prediabetes.

INDIANAPOLIS – Eli Lilly is spending $140 million to expand its insulin manufacturing plant in Indianapolis, the drug maker said.

Lilly said it would expand the plant by 80,000 sq. ft., saying it represented one of the most significant investments in its U.S. manufacturing operations in the past decade. Construction is expected to start immediately, with completion planned for March 2014.